ReductionReagent: 10 mM DTT  
AlkylationReagent: 55 mM iodoacetamide  
ConcentrationOfCompound: 4% SDS  
ConcentrationOfCompound: 10 mM Hepes pH 8.0  
CleavageAgent: LysC  
CleavageAgent: trypsin  
Modification: carbamidomethylation  
Modification: acetylation (N terminus)  
Modification: methionine oxidation  
Separation: chromatographic separation using relatively long (4 h) HPLC gradients  
GradientTime: 250 min gradient from 2% to 60%  
FlowRateChromatogram: 200 nl min−1  
IonizationType: nano electrospray source  
Instrument: Q Exactive  
Instrument: Q Exactive HF  
FragmentationMethod: high-energy collisional dissociation fragmentation  
AcquisitionMethod: A top-five method  
CollisionEnergy: normalized collision energy of 25  
CollisionEnergy: normalized collision energy of 27  
AssayName: Label-free protein quantification (LFQ)  
Temperature: 99 °C  
Temperature: −80 °C  
Temperature: 50 °C  
Temperature: 95 °C  
Time: 10 min  
Time: 15 min  
Time: 30 min  
Time: overnight  
NumberOfSamples: eight  
NumberOfSamples: 30  
NumberOfSamples: three  
NumberOfBiologicalReplicates: n=3  
Treatment: 7 μM ATRA daily for 7 days  
SampleTreatment: Antigen retrieval in 0.01 M sodium citrate buffer with 0.05% Tween 20 (pH 6.0) for 30 min at 95 °C  
MaterialType: Frozen tumour samples  
MaterialType: Formalin-fixed paraffin-embedded HGSOC and normal tissue sections  
Specimen: primary fallopian tube secretory epithelial cells (FTECs)  
Organism: human  
TumorStage: FIGO Stage IIIB/C  
SupplementaryFile: PXD003668